Actively Recruiting
Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis
Led by The University of Texas Health Science Center at San Antonio · Updated on 2026-01-06
28
Participants Needed
1
Research Sites
110 weeks
Total Duration
On this page
Sponsors
T
The University of Texas Health Science Center at San Antonio
Lead Sponsor
N
National Center for Advancing Translational Sciences (NCATS)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The study will test and compare the efficacy of a single essential amino acid valine with a combination of essential amino acids (EAA) supplement on fatigue, frailty, and cognitive function in end-stage kidney disease (ESKD) patients undergoing hemodialysis (HD) treatment.
CONDITIONS
Official Title
Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or Female
- Age 18 to 64 years
- Receiving in-clinic hemodialysis three times weekly for at least 6 months
You will not qualify if you...
- Allergy or hypersensitivity to amino acids or any ingredients in supplements
- Clinical diagnosis of COVID-19
- Taking other amino acid supplements concurrently
- Current use or abuse of alcohol, marijuana, narcotics, or other substances
- Heart failure requiring active treatment
- Malignant cancer undergoing anticancer therapy
- Major depressive disorder being treated with antidepressants
- Chronic liver disease diagnosis
- Cerebrovascular disease with lasting effects
- Upper limb amputation, osteoarthritis, degenerative finger diseases, or carpal tunnel syndrome in the non-fistula or graft hand that prevents hand grip strength testing
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States, 78229
Actively Recruiting
Research Team
S
Subrata Debnath, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here